Patents Prosecuted
| Application number | Title of the patent | IPC | Filing Date | Decision Date |
|---|---|---|---|---|
| 18157696 | DRUG DELIVERY DEVICE | A61M | Jan 19, 2023 | |
| 18157472 | PLUNGER AND DRUG DELIVERY DEVICE | A61M | Jan 19, 2023 | |
| 18155655 | SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF | A61K, C12N | Jan 16, 2023 | |
| 18152513 | Injector device | A61M | Jan 9, 2023 | Dec 4, 2023 |
| 18147459 | Sensor System | A61M | Dec 27, 2022 | |
| 18067940 | ANTIGENIC EPSTEIN BARR VIRUS POLYPEPTIDES | C07K, A61K | Dec 18, 2022 | |
| 18066175 | METHODS TO PRODUCE ROD-DERIVED CONE VIABILITY FACTOR (RDCVF) | C07K | Dec 13, 2022 | |
| 18066149 | GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL CORD DISORDERS | A61K | Dec 13, 2022 | |
| 18077642 | Determining a status of an injection | A61M | Dec 7, 2022 | Jan 22, 2024 |
| 18054734 | TRISPECIFIC ANTI-CD38, ANTI-CD28, AND ANTI-CD3 BINDING PROTEINS AND METHODS OF USE FOR TREATING VIRAL INFECTION | C07K, A61P, C12N | Nov 10, 2022 | |
| 17985531 | Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions | C07D | Nov 10, 2022 | Nov 13, 2023 |
| 18054500 | Gene therapy for neurodegenerative disorders | A61K, C12N, C07K | Nov 9, 2022 | Feb 26, 2024 |
| 17983883 | Isoxazolidines as RIPK1 inhibitors and use thereof | C07D | Nov 8, 2022 | Feb 12, 2024 |
| 17983209 | Implantable Glucose Monitor | A61B | Nov 7, 2022 | |
| 18051468 | TREATMENT OF OSTEOGENESIS IMPERFECTA | C07K, A61P, A61K | Oct 30, 2022 | |
| 17971118 | CARTRIDGE WITH DISTRIBUTED ELECTRONIC COMPONENTS | A61M | Oct 20, 2022 | |
| 18046363 | Gene Therapy For Neurodegenerative Disorders | A61K, C07K, C12N | Oct 12, 2022 | |
| 17958817 | INJECTION DEVICE WITH AN ACOUSTIC FEEDBACK ARRANGEMENT | A61M | Oct 2, 2022 | |
| 17937405 | Process for Preparing Sartan Active Compounds Having a Tetrazole Ring | C07D | Sep 29, 2022 | |
| 17956420 | INJECTOR DEVICE | A61M | Sep 28, 2022 |